trending Market Intelligence /marketintelligence/en/news-insights/trending/zXujBGk-0Dnn2_MCya9QmA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Knight Therapeutics ups stake in Crescita

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Knight Therapeutics ups stake in Crescita

Knight Therapeutics Inc. upped its stake in Crescita Therapeutics Inc. by 4% to 14.9%.

The company acquired 566,471 new Crescita shares and continues to hold 396,000 warrants, which, if fully exercised, will increase its stake by an additional 2.3%.

The new shares were issued as part of an agreement dated Aug. 31, 2016.

Knight now owns a total of 2,079,973 Crescita shares, which are held for investment purposes.